Pryce Introduces Bill To Reimbuse For Orally Administered Cancer Drugs.
H. Lee Moffitt Cancer Designated A Comprehensive Cancer Center By NCI.
DeMets Receives Lectureship On Epidemiology From NIH.
Generic Paclitaxel Approval Withstands Court Challenge.
Obit: J. Gale Katterhagen, NCAB’s First Community Physician.
NCI Invites “Extraordinary Opportunities” For Research. Groups Planning Promotion Of Cancer Clinical Trials.
FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.
M. D. Anderson Buys Record System For In-Patient Services From Atlanta Firm.
Genetronics Phase II Trials For Head & Neck Completed.
Biomira Ends Agreement On Lymphoma Vaccine.
Trending Stories
- How a Georgetown med school student found her calling in surgery, law, and health equity
- Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Laurie Glimcher to step down as Dana-Farber president and CEO, Benjamin Levine Ebert named successor
- Lei Zheng got his PhD in San Antonio; now he returns as cancer center director at Mays
- As NCI’s appropriations stay flat, Rathmell keeps the FY26 bypass budget steady at just under $11.5B
Rathmell: “We understand that there are real economic constraints facing our country and the world. But our gap just can’t keep widening.” - Huiping Liu discusses mentorship, translational research on the UChicago Cancer Luminaries podcast